Business · 08/11/2016
FDA Releases Guidance on Non-Inferiority Clinical Trials for Drug and Biologic Effectiveness
The Food and Drug Administration (FDA) has published a guidance document outlining the use of non-inferiority clinical trials to demonstrate the effectiveness of investigational drugs and biologics, providing clarity for industry sponsors and applicants.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →